BHCM
VXRT

Brevan Howard Capital Management’s Vaxart VXRT Stock Holding History

Brevan Howard Capital Management’s Portfolio VXRT Stock Details VXRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-44,864
Closed -$58.3K – 1422
2024
Q1 		$58.3K Buy
+44,864
New +$47K ﹤0.01% 931

Other funds holding VXRT

SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brevan Howard Capital Management's VXRT Position: Q2 2024 in Review

Brevan Howard Capital Management sold out of Vaxart (VXRT) in Q2 2024, closing a stake of 44,864 shares — an estimated $58.3K sold.

Brevan Howard Capital Management first reported a position in VXRT in Q1 2024 and held it in 1 quarter. The position peaked at $58.3K in Q1 2024. 100 funds tracked by Wall St. Rank hold VXRT as of Q2 2024.

  • Brevan Howard Capital Management reported no remaining Vaxart position as of Q2 2024 after selling out during the quarter.
  • Brevan Howard Capital Management sold 44,864 Vaxart shares in Q2 2024, an estimated $58.3K.
  • Brevan Howard Capital Management first reported a position in Vaxart in Q1 2024 and held it in 1 quarter.
  • Brevan Howard Capital Management's Vaxart position peaked at $58.3K in Q1 2024.
  • 100 funds tracked by Wall St. Rank held Vaxart as of Q2 2024.

Based on Brevan Howard Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.